Company CannaPharmaRX, Inc. Other OTC
Equities
CPMD
US13765D1090
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dean Medwid
CEO | Chief Executive Officer | - | 23-05-31 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 16-12-31 |
Oliver Foeste
DFI | Director of Finance/CFO | 48 | 23-10-12 |
John Cassels
AUD | Comptroller/Controller/Auditor | 75 | 19-04-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Orman
BRD | Director/Board Member | 74 | 19-04-22 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 16-12-31 |
Anthony Panek
BRD | Director/Board Member | 39 | 23-08-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,455,000 | 0 | 0 | 98.62 % |
Stock B | 1 | 668,732,166 | 659,614,589 ( 98.64 %) | 6,230,761 ( 0.9317 %) | |
Stock C | 0 | 84,416 | 0 | 0 |
Company contact information
CannaPharmaRx, Inc.
888 3rd Street South West Suite 3600
T2P 5C5, Calgary
+
http://www.cannapharmarx.comSector
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |